Skip to main content
Iranian Journal of Public Health logoLink to Iranian Journal of Public Health
. 2022 May;51(5):990–998. doi: 10.18502/ijph.v51i5.9414

Self-Medication Profile of Adult Patients with Temporomandibular Disorders in Southeast Brazil

Tomie T De Campos 1,*, Lena Katekawa 1, Rosemary S A Shinkai 2, Ricardo J Furuyama 1, Reinaldo Missaka 1, Daniela Mita 1, Ana Paula L De Oliveira 3
PMCID: PMC9643244  PMID: 36407742

Abstract

Background:

Patients with temporomandibular disorder (TMD) often have orofacial pain and may use medication without professional prescription. Self-medication and inappropriate drug intake may cause serious health problems. This cross-sectional study evaluated the self-medication profile of TMD patients, the most used medications and their effect, and the relation between self-medication and socioeconomic factors.

Methods:

A non-representative sample (n=358) consisted of consecutive adult patients seeking TMD treatment in specialized referral centers for orofacial pain of two universities in São Paulo city, Brazil. A standardized questionnaire was used to collect the study variables before the TMD treatment: self-medication history, TMD pain intensity, sex, age, ethnicity, marital status, schooling and socioeconomic levels. Data were analyzed by descriptive statistics, chi-square test, and logistic regression models at the 0.05 significance level.

Results:

Almost 60% of 358 TMD patients reported self-medication. Patients with severe TMD were 4.7 times more likely to self-medicate when compared to patients with low TMD intensity (O=5.7; 95% CI=2.4; 13.3; P=0.043), as well as female patients were 30% more likely to self-medicate compared to male patients (OR=2.3; 95% CI=1.1; 5.1; P<0.001). The other independent variables were not associated with self-medication. The frequencies of moderate and severe TMD in women were larger than in those in men (P<0.001). Analgesics and anti-inflammatory drugs were the most used medications. Regarding medication efficacy, 82% of patients reported some improvement after use, but 9% reported side-effect sickness.

Conclusion:

Self-medication is common among TMD patients attending specialized clinics, and this inappropriate practice is more likely to occur in women and in patients with severe signs and symptoms of TMD.

Keywords: Self-medication, Temporomandibular disorder, Orofacial pain, Analgesics

Introduction

More than 31% of the adults and elderly worldwide have one or more signs and symptoms of temporomandibular disorder (TMD) (1), which is more frequent in women and the middle-aged adults (24). The main complaints are headache, orofacial pain and discomfort during mandibular movements and in rest position (5). TMD etiology is complex, multifactorial, and patient-specific. Early TMD has a non-inflammatory origin: the pathological process is characterized by degeneration and abrasion of the joint cartilage and local thickness. These alterations are followed by superimposition of secondary inflammatory events, but ageing, systemic diseases, and hormonal factors may interfere in the patient’s adaptive capacity (6). One risk factor for TMD is the presence of chronic pain, which in turn can be triggered by psychological distress, health problems, sleep disturbances, fatigue, and nutritional deficiencies (7, 8). Moreover, TMD may coexist with other pain conditions, such as fibromyalgia, back and lumbar pain, headache, arthritis, autoimmune diseases, gastrointestinal problems, allergy, depression, fatigue, and sleep apnea (2, 710).

As pain interferes with sleep quality, productive capacity, and social and affective relations, TMD patients may use drugs for pain relief before seeking professional healthcare. Self-medication can be defined as the selection and use of medication to prevent or treat symptoms and diseases with no prescription or orientation by a physician or a dentist (11). Self-medication comprises industrialized, synthetic, natural, or homemade substances.

Approximately 36 million people are estimated to use analgesics daily without prescription in the United States (12). In Brazil, self-medication also is common (13), and analgesics are the most used drugs (14). Self-medication is necessary and complements the health systems in poor and developing countries, the WHO had published guidelines to regulate drug utilization monitoring, including the medications that could be used for self-medication with efficacy, safety, and easy administration (15).

Many medications may be exempt from prescription but not from risk. In self-medication, the users may not follow the manufacturer’s indications resulting in inappropriate intake regarding dosage, time, or possible drug interactions. For example, the abuse of dipyrone has serious safety issues (15), and headaches can be caused by excessive use of analgesics (1620). Moreover, overuse, possible intoxication, and adverse effects may increase the expenditures in the public health system (1720). Several factors can influence in the clinical therapeutic effect, such as chronic administration, age, general health, and habits (12). Nevertheless, it still is unclear to what extent self-medication occurs in TMD patients.

We aimed at evaluating the self-medication profile of TMD adult patients, the most used medications, their effect after intake, and the relation between self-medication and socioeconomic factors in a sample from the largest city in Brazil.

Materials and Methods

Study design and sample

The study design was a cross-sectional, dual-site survey. It followed the recommendations of the Declaration of Helsinki and the Resolution 466/12 of the Brazilian Ministry of Health. The research protocol was approved by the institutional Review Boards of the University of São Paulo (No.317.640) and the University Nove de Julho (No.285.532) and was registered in the Brazilian system for human research (CAAE 14443213.8.3001.0075).

A non-probabilistic sample consisted of consecutive patients seeking TMD treatment at a specialized clinic of two dental schools: 1) the Centre of Occlusion, Temporomandibular Dysfunction, and Orofacial Pain of the University of São Paulo Dental School, in São Paulo, Brazil, and 2) the Specialization Course in Prosthodontics of the University Nove de Julho, in São Paulo, Brazil. Both specialized referral units are located in São Paulo city, in Southeast Brazil.

The inclusion criteria were: Age over 18 yr; adult patients with spontaneous pain or with pain evoked by palpation of face, cranium or temporomandibular joint (TMJ), in static position or during mandibular movements; no toothache at the start of the study. The exclusion criteria were: Incidence of toothache during the study; treatment with medication in the last six months; mental or psychological problems that could compromise the patient’s responses.

Procedures

The selected patients were invited to participate in the study and received individual information on the research protocol and confidentiality of personal data. Those who accepted to participate in the study signed a written informed consent form.

All procedures for data collection were performed by a trained examiner and dental specialist before the TMD treatment. Each patient answered a standardized questionnaire to grade TMD intensity based on restrictions to mandibular movement, orofacial pain and discomfort, cranio-cervical pain, and joint noises (21). Afterwards, the patient answered questions related to self-medication by using an instrument modified from Servidone et al. (22) on socioeconomic variables and on medication data: posology, use of medication, reason for self-medication, knowledge on medication, awareness of the manufacturer’s information.

Data were analyzed by descriptive statistics, logistic regressions, and chi-square tests at the 0.05 significance level. In the multivariate analysis, logistic regression was used to look at factors that were mostly associated with self-medication. Initially, univariate logistic regression was used to calculate crude odds ratios (ORs). Missing values were disregarded. In the multivariate analysis, all variables potentially associated with self-medication were included. A stepwise procedure was used for the selection of joint variables associated with self-medication, with variables included and excluded in each step based on the likelihood ratio. All analyses were performed with SPSS Statistics, ver. 22.0 (IBM Corp, Armonk, NY).

Results

The study sample consisted of 358 TMD patients (84.4% women) with a mean age of 41 yr old (standard deviation =13). Self-medication was reported by 210 (58.6%) of TMD patients.

Table 1 shows the distribution of self-medication per variable, and the results of the univariate and multivariate models of logistic regression. Through logistic regression, in the univariable model only the variables TDM Intensity and Sex were associated with self-medication. These were also the only variables that remained in the multivariable model, where patients with severe TMD were 4.7 times more likely to self-medicate when compared to patients with low TMD intensity (O=5.7; 95% CI=2.4; 13.3), as well as female patients are 30% more likely to self-medicate when compared to male patients (OR=2.3; 95% CI=1.1; 5.1). The distribution of participants according to TMD intensity was 50% severe, 35% moderate, and 15% low. The frequencies of moderate and severe TMD in women were larger than in those in men (P<0.001) (Table 2). Table 3 summarizes the self-medication practices reported by this sample of TMD patients. Most respondents have read (75%) and followed (66%) the drug manufacturer’s information, but they were aware that self-medication could be harmful to their health (77%). The most reported self-medication categories were analgesics (46.4%) and anti-inflammatory drugs (34.4%) (Fig. 1).

Table 1:

Descriptive statistics of the sample (n = 358) and logistic regression models for self-medication and independent variables

Variable Self-medication Univariate model Multivariate model
Variable Total % Yes OR (95%CI) P OR (95%CI) P
TMD intensity low 55 29 1 1
moderate 122 50 2.4 (1.2 ; 4.8) 0.010 1.8 (0.8 ; 4.3) 0.172
severe 181 73 6.8 (3.5 ; 13.2) 0.000 5.7 (2.4 ; 13.3) 0.000
Sex female 302 64 4.1 (2.2 ; 7.5) 0.000 2.3 (1.1 ; 5.1) 0.043
male 56 30 1 1
Age group Young adult 174 61 1
Middle-aged 146 55 0.8 (0.5 ; 1.3) 0.398
Old adult 38 63 1.1 (0.5 ; 2.3) 0.758
Ethnic group Caucasian 240 63 1
African 60 60 0.7 (0.4 ; 1.2) 0.174
Asian 16 56 0.5 (0.1 ; 1.8) 0.272
Marital status Married 158 61 1
Single 145 56 1.3 (0.8 ; 2.0) 0.329
Other 38 55 1.1 (0.6 ; 2.2) 0.667
Schooling (complete grade) 3rd grade 157 60 1
2nd grade 67 52 0.5 (0.2 ; 1.6) 0.240
1st grade 10 60 0.5 (0.2 ; 1.6) 0.269
Socio economic level A 23 56 1
B1 75 56 1.0 (0.4 ; 2.5) 0.965
B2 101 58 1.1 (0.4 ; 2.7) 0.868
C1 51 59 1.1 (0.4 ; 3.0) 0.853
C2 55 58 1.1 (0.4 ; 2.9) 0.892
D 36 64 1.4 (0.5 ; 4.0) 0.572

Table 2:

Comparison of TMD intensity levels according to sex

Variable TMD intensity
Low Moderate * Severe * Total
Female 35 102 165 302
Sex Male 20 20 16 56
Total 55 122 181 358
*

Significant difference between groups (chi-square tests, P<0.001)

Table 3:

Self-medication information reported by TMD patients (n = 210)

Self-medication details Yes %
Read the manufacturer’s information 157 75
Followed the manufacturer’s information 139 66
Followed indications from friends or family 79 38
Followed recommendation from a drugstore attendant 42 20
Followed TV marketing 7 3
Followed internet marketing 11 5
Followed marketing on radio, newspaper or magazine 1 0.5
Used an old prescription 115 55
Felt that the self-medication was efficacious 173 82
Felt sick after self-medication 23 11
Believes that self-medication is bad for health 161 77

Fig. 1:

Fig. 1:

Type of self-medication reported by TMD patients (n = 210) according to TMD intensity levels

Discussion

This study showed that almost 60% of TMD patients used self-medication. Respondents with severe TMD and female patients were more likely to self-medicate when compared to their counterparts, but the other socioeconomic variables, e.g., age, ethnicity, marital status, schooling and socioeconomic levels, did not affect self-medication practice. Analgesics and anti-inflammatory drugs were the most reported self-medication products. To the best of the authors’ knowledge, this is the first study to investigate self-medication in a large sample of TMD patients.

Most TMD patients of the present sample were women, Caucasian, adults in their 40’s, married or single, of both high schooling and socioeconomic levels, and with severe and moderate intensity of TMD signs and symptoms. This distribution can be explained the study was performed in two specialized TMD referral centers, located in São Paulo, the largest capital city in Brazil. Besides spontaneous walk-in patients, these university TMD centers receive patients from other dental clinic units, universities, hospitals, and healthcare professionals in the metropolitan region. However, the study sample was not probabilistic and representative of the city population, and the findings should not be extrapolated directly to other clinical settings.

More than half of the 358 TMD patients in the present sample (58.6%) reported self-medication, which is lower than the 76% non-specific patients who confirmed general self-medication in a medium-size city in the southern Brazil countryside (23). 83% of Brazilian otorhinolaryngologic patients had bought or used medication without prescription (22). However, the purchase or use of medication was not restricted to otorhinolaryngologic problems and may have other health complaints. The figures of the present study also were lower than the prevalence of self-medication found in southern Iran for university students of Medical Sciences (72.3%) (24) and for city dwellers and village residents (78.7%) (25). Therefore, self-medication is a common inappropriate practice that occurs across populations with diverse background and healthcare needs.

Regarding TMD intensity, self-medication was much more frequent in patients with severe signs and symptoms, explained by the fact that TMD pain can be debilitating and impact daily living negatively (2, 6, 10). Conversely, near 30% of patients with low intensity TMD reported self-medication, and those with moderate TMD were not more likely to use self-medication, suggesting that these two groups could manage pain otherwise. These findings highlight the importance to distinguish behavioral practices among patients with different TMD severity levels and to reinforce professional advice to prevent medication overtreatment.

The sample of the present study had a ratio of 5.4 for women in relation to men and showed that female patients reported more moderate and severe TMD than male patients. Although the sample was not probabilistic, these figures should reflect the routine attendance of the two evaluated centers as TMD is more prevalent in women than men both in Brazil (21) and abroad (2, 3). Slade et al. (26) cite biological, hormonal, and psychological reasons to justify this sex-difference in TMD prevalence. A study in rats found that estradiol and testosterone reduced the joint inflammation and nociception of induced TMD (4), which could explain the role of sexual hormones in the disease mechanism.

This study showed that the percentage of women reporting self-medication was higher (64%) than that of men (30%), which corroborates previous studies in Brazil (22, 23) and in Greece (27). However, the same effect is not observed in other studies. For instance, in Iran, the self-medication prevalence was not different between female and male Medical Science students (24), but it was higher in men in a community-dwelling survey (25). Other socioeconomic variables, such as age and education, also showed effect on self-medication practice (25) or not (24) depending on the study. The results may be influenced by the sample heterogeneity, ratio between women and men, specific main independent variable of interest, and other factors, such as decision-making autonomy and access to formal healthcare.

In this sample, self-medication was not associated with age, ethnicity, marital status, schooling and socioeconomic levels, also reported previously (11). In relation to age, self-medication is a geriatric concern due to the increased exposure to polypharmacy, medication interaction, and mistakes in dosage and administration time. However, the present study did not find any difference in self-medication among young adults (18 to 39 yr old), middle-aged (40 to 59 yr old), and old adults (60 yr old and over). Schooling and socioeconomic levels were not associated with self-medication as well, considering that the sample was derived from the urban population of the largest city in Brazil. One could expect that less education and low financial conditions would lead to inappropriate healthcare practices such as self-medication. This was found in a study with Iranian adults, mostly living in urban areas, which reported that people with more years of education were less likely to self-medication behavior (25). Conversely, an opposite possibility would be that higher education could give patients more confidence to practice self-healthcare and have more access to drugs (23).

Analgesics and anti-inflammatory drugs for relief of pain, discomfort, and inflammation were the most used drugs for self-medication, which is in agreement with previous studies (14, 16, 22, 23, 28). Most patients reported that the medication was indicated by friends, family or old prescription. Although the media and industry marketing could have a strong influence on medication consumption, few patients reported that. The drug choice often is based on the recommendation of laypersons, and the over-the-counter commerce favors the drug acquisition without professional prescription (29). Many drugs are purchased for family use, which may represent a household economic saving but also facilitates improper health treatment (16). Others share medications with friends and relatives, use remaining drugs from previous prescriptions (30), or reuse old prescriptions (23). Among Iranian Medical Sciences students, having a medicine stock was the main factor leading to self-medication practice (24). Therefore, the availability of existing drugs and opportunity of using them may increase self-medication practice across different populations.

Most TMD patients under self-medication stated that they have read and followed the manufacturer’s indications, and they were aware that self-medication can be harmful. Indeed, almost 10% reported feeling sick after intake of medication without professional orientation, although 82% reported that self-medication had some efficacy. Several medications and substances taken by the patients in this sample are not indicated for TMD problems. Another concern is that most patients had severe TMD signs and symptoms and may not have followed the ideal drug posology, which could lead to higher dosage and reduced administration time. Therefore, it is important to inform patients, caregivers, and professionals of this additional problem with self-medication.

Some limitations regarding the study design and the sample from a major metropolis do not allow causal-effect analysis or extrapolation for TMD patients in small cities and rural areas. The lack of similar studies on self-medication in TMD patients warrants further investigation to develop appropriate clinical protocols and information material for patients and dental staff. Self-medication is a public health problem, and the WHO has launched a global initiative to reduce 50% of serious and preventable harm associated with drugs in all countries by 2022.

Conclusion

Self-medication is common among TMD patients attending specialized clinics, and this inappropriate practice is more likely to occur in women and in patients with severe signs and symptoms of TMD. Most patients used medications indicated by friends and relatives, or from old professional prescriptions. Furthermore, the effect of self-medication with analgesics and anti-inflammatory drugs is of short duration and may have adverse effects. Therefore, clinical examination for TMD treatment should include evaluation of self-medication for precise diagnosis, comprehensive treatment planning, and successful health-care delivery.

Journalism Ethics considerations

Ethical issues (Including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.

Acknowledgements

The authors would like to thank the dental clinical staff at the Centre of Occlusion, Temporomandibular Dysfunction, and Orofacial Pain of the University of São Paulo Dental School, and the Specialization Course in Prosthodontics of the University Nove de Julho. This study received no research funding.

Footnotes

Conflict of interest

The authors declare that there is no conflict of interest.

References

  • 1.Valesan LF, Da-Cas CD, Réus JC, et al. (2021). Prevalence of temporomandibular joint disorders: a systematic review and meta-analysis. Clin Oral Investig, 25: 441–453. [DOI] [PubMed] [Google Scholar]
  • 2.Hoffmann RG, Kotchen JM, Kotchen TA, et al. (2011). Temporomandibular disorders and associated clinical comorbidities. Clin J Pain, 27: 268–274. [DOI] [PubMed] [Google Scholar]
  • 3.Gonçalves DA, Dal Fabro AL, Campos JA, et al. (2010). Symptoms of temporomandibular disorders in the population: an epidemiological study. J Orofac Pain, 24: 270–278. [PubMed] [Google Scholar]
  • 4.Torres-Chaves KE, Sanfins JM, Clemente-Napinoga JT, et al. (2012). Effect of gonodal steroid hormones on formalin-induced temporomandibular joint inflammation. Eur J Pain, 16: 204–216. [DOI] [PubMed] [Google Scholar]
  • 5.Gonçalves DA, Bigal ME, Jales LCF, et al. (2010). Headache and symptoms of temporomandibular disorder: an epidemiological study. Headache, 50: 231–241. [DOI] [PubMed] [Google Scholar]
  • 6.Tanaka E, Detamore MN, Mercuri LG. (2008). Degenerative disorders of the temporomandibular joint: etiology, diagnosis, and treatment. J Dent Res, 87 :296–307. [DOI] [PubMed] [Google Scholar]
  • 7.Aggarwal VR, Mcfarlane GJ, Farragher TM, et al. (2010). Risk factors for onset of chronic oral-facial pain: results of the North Cheshire oro-facial pain prospective population study. Pain, 149: 354–359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lim PF, Maixner W, Khan AA. (2011). Temporomandibular disorder and comorbid pain conditions. J Am Dent Assoc, 142: 1365–1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sanders AE, Slade GD, Bair E, et al. (2013). General health status and incidence of first-onset temporomandibular disorder: the OPPERA prospective cohort study. J Pain, 14: T51–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Slade GD, Ohrbach R, Greenspan JD, et al. (2016). Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies. J Dent Res, 95:1084–1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Oliveira MA, Francisco PMSB, Costa KS, et al. (2012). Self-medication in the elderly population of Campinas, São Paulo State, Brazil: prevalence and associated factors. Cad Saúde Pública, 28: 335–345. [DOI] [PubMed] [Google Scholar]
  • 12.Hersh EV, Pinto A, Moore PA. (2007). Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin Ther, 29: 2477–2497. [DOI] [PubMed] [Google Scholar]
  • 13.Arrais PSD, Fernandes MEP, Pizzol TS, et al. (2016). Prevalence of self-medication in Brazil and associated factors. Rev Saude Publica, 50: 13s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.da Silva Dal Pizzol T, Turmina Fontanella A, Cardoso Ferreira MB, et al. (2019). Analgesic use among the Brazilian population: Results from the National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM). Plos One, 14 (3): e0214329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.WHO Collaborating Centre for Drug Statistics Methodology (2019). Guidelines for ATC classification and DDD assignment 2020. Oslo: WHO. [Google Scholar]
  • 16.Arrais PSD, Coelho HLL, Batista MCDS, et al. (1997). Aspects of self-medication in Brazil. Rev Saúde Pública, 30: 71–77. [DOI] [PubMed] [Google Scholar]
  • 17.Diener HC, Limmroth V. (2004). Medication-overuse headache: a worldwide problem. Lancet Neurol, 3: 475–483. [DOI] [PubMed] [Google Scholar]
  • 18.Evers S, Marziniak M. (2010). Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol, 9: 391–401. [DOI] [PubMed] [Google Scholar]
  • 19.Westergaard ML, Hansen EH, Glumer C, et al. (2014). Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review. Cephalalgia, 34: 409–425. [DOI] [PubMed] [Google Scholar]
  • 20.Diener HC. (2014). Treating medication overuse headache: more than improving headache. Cephalalgia, 34: 405–406. [DOI] [PubMed] [Google Scholar]
  • 21.Silveira AM, Feltrin PP, Zanetti RV, et al. (2007). Prevalence of patients harboring temporomandibular disorders in an otorhinolaryngology department. Braz J Otorhinolaryngol, 73: 528–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Servidone AB, Coelho L, Navarro ML, et al. (2006). Self-medication profile of ENT patients. Braz J Otorhinolaryngol, 72: 83–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Vilarino JF, Soares JC, Silveira CM, et al. (1998). Self-medication profile in a city in South Brazil. Rev Saude Publica, 32: 43–49. [DOI] [PubMed] [Google Scholar]
  • 24.Niroomand N, Bayati M, Seif M, et al. (2020). Self-medication pattern and prevalence among Iranian Medical Sciences students. Curr Drug Saf, 15: 45–52. [DOI] [PubMed] [Google Scholar]
  • 25.Khajeh A, Vardanjani HM, Salehi A, et al. (2019). Healthcare-seeking behavior and its relating factors in South of Iran. J Educ Health Promot, 8: 183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Slade GD, Bair E, Greenspan JD, et al. (2013). Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: The OPPERA prospective Cohort study. J Pain, 14(12 Suppl):T20-32.e1-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Papakosta M, Zavras D, Niakas D. (2014). Investigating factors of self-care orientation and self-medication use in a Greek rural area. Rural Remote Health, 14: 2349. [PubMed] [Google Scholar]
  • 28.Pastore GP, Goulart DR, Pastore PR, et al. (2018). Self-medication among myofascial pain patients: A preliminary study. Open Dent J, 12: 347–353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bond C, Hannaford P. (2003). Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug Saf, 26: 1065–1074. [DOI] [PubMed] [Google Scholar]
  • 30.Segall A. (1990). A community survey of self-medication activities. Med Care, 28: 301–310. [DOI] [PubMed] [Google Scholar]

Articles from Iranian Journal of Public Health are provided here courtesy of Tehran University of Medical Sciences

RESOURCES